Sandoz Gains 5% as Biosimilars Fuel Ambitious 2035 Growth Target

3-line summary

• Sandoz shares gained 5% as biosimilars fuel an ambitious 2035 growth target, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.